20,260.00
-135.00
(-0.66%)
At close: 3:45:00 PM GMT+9
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
792,628,000.00
792,628,000.00
734,095,000.00
670,325,000.00
558,264,000.00
Cost of Revenue
104,638,000.00
104,638,000.00
102,240,000.00
103,042,000.00
83,288,000.00
Gross Profit
687,990,000.00
687,990,000.00
631,855,000.00
567,283,000.00
474,976,000.00
Operating Expense
254,537,000.00
254,537,000.00
230,991,000.00
203,811,000.00
170,421,000.00
Operating Income
433,453,000.00
433,453,000.00
400,864,000.00
363,472,000.00
304,555,000.00
Net Non Operating Interest Income Expense
-1,925,000.00
-1,925,000.00
-1,816,000.00
-1,664,000.00
-2,010,000.00
Pretax Income
236,564,000.00
236,564,000.00
215,832,000.00
210,706,000.00
159,218,000.00
Tax Provision
53,998,000.00
53,998,000.00
47,044,000.00
45,384,000.00
33,997,000.00
Net Income Common Stockholders
181,377,000.00
181,377,000.00
168,638,000.00
164,507,000.00
125,446,000.00
Diluted NI Available to Com Stockholders
181,377,000.00
181,377,000.00
168,638,000.00
164,507,000.00
125,446,000.00
Basic EPS
515.48
--
469.76
446.45
335.77
Diluted EPS
515.27
--
469.47
445.93
335.25
Basic Average Shares
351,857.00
--
358,986.00
368,482.00
373,602.00
Diluted Average Shares
352,003.00
--
359,207.00
368,908.00
374,188.00
Total Expenses
359,175,000.00
359,175,000.00
333,231,000.00
306,853,000.00
253,709,000.00
Net Income from Continuing & Discontinued Operation
181,376,000.00
181,376,000.00
168,638,000.00
164,507,000.00
125,446,000.00
Normalized Income
188,191,239.62
188,191,239.62
169,484,160.98
165,353,230.00
131,864,476.00
Interest Income
--
--
--
--
478,000.00
Interest Expense
1,925,000.00
1,925,000.00
1,816,000.00
1,664,000.00
2,010,000.00
Net Interest Income
-1,925,000.00
-1,925,000.00
-1,816,000.00
-1,664,000.00
-2,010,000.00
EBIT
238,489,000.00
238,489,000.00
217,648,000.00
212,370,000.00
161,228,000.00
EBITDA
285,704,000.00
285,704,000.00
267,263,000.00
255,389,000.00
197,564,000.00
Reconciled Cost of Revenue
104,638,000.00
104,638,000.00
102,240,000.00
103,042,000.00
83,288,000.00
Reconciled Depreciation
47,215,000.00
47,215,000.00
49,615,000.00
43,019,000.00
36,336,000.00
Net Income from Continuing Operation Net Minority Interest
181,376,000.00
181,376,000.00
168,638,000.00
164,507,000.00
125,446,000.00
Total Unusual Items Excluding Goodwill
-8,831,000.00
-8,831,000.00
-1,082,000.00
-1,078,000.00
-8,166,000.00
Total Unusual Items
-8,831,000.00
-8,831,000.00
-1,082,000.00
-1,078,000.00
-8,166,000.00
Normalized EBITDA
294,535,000.00
294,535,000.00
268,345,000.00
256,467,000.00
205,730,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-2,015,760.38
-2,015,760.38
-235,839.02
-231,770.00
-1,747,524.00
3/31/2021 - 1/1/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4543.T Terumo Corporation
2,991.00
-0.03%
6869.T Sysmex Corporation
2,943.50
+1.08%
SAUHY Straumann Holding AG
12.70
-0.08%
7733.T Olympus Corporation
2,344.00
+1.12%
ESL.MU Essilorluxottica
235.20
0.00%
STMN.SW Straumann Holding AG
118.40
+1.50%
AVTR Avantor, Inc.
22.02
+1.66%
WST West Pharmaceutical Services, Inc.
339.60
+2.37%
COO The Cooper Companies, Inc.
91.28
+1.07%
AFX.DE Carl Zeiss Meditec AG
46.42
-0.43%